MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
534.77%
Quick Ratio
497.13%
Cash Ratio
414.32%
Debt to Asset Ratio
89.51%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable (net of allo...
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Long-term debt
    • Others
Balance Sheets
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
46,288
20,439
22,687
26,490
Accounts receivable (net of allowance of 98 and 24, respectively)
6,459
6,558
5,000
5,571
Inventory, net
4,205
3,077
3,276
3,807
Prepaid expenses
2,792
2,170
2,365
2,216
Total current assets
59,744
32,244
33,328
38,084
Property and equipment, net
1,837
1,808
1,826
1,711
Right-of-use assets
798
861
890
1,103
Other assets
69
418
419
419
Total assets
62,448
35,331
36,463
41,317
Trade payables
3,763
3,002
3,784
1,902
Accrued liabilities
7,107
8,096
6,773
7,078
Short-term lease liabilities
244
167
129
123
Other current liabilities
58
234
224
221
Total current liabilities
11,172
11,499
10,910
9,324
Long-term debt
33,065
33,046
32,764
32,274
Revenue base redemption liability
489
383
502
358
Long-term lease liabilities
1,117
1,228
1,231
1,265
Contingent earnout liability
3,738
10,144
4,997
7,522
Warrant liabilities
6,317
12,892
12,784
9,997
Total liabilities
55,898
69,192
63,188
60,740
Common stock, 0.0001 par value, 400,000,000 shares authorized at june30, 2026 and december31, 2025, respectively 61,469,572 shares and 49,997,836 shares issued and outstanding at june30, 2026 and december31, 2025, respectively
5
4
4
3
Additional paid-in capital
344,776
296,718
294,241
278,786
Accumulated deficit
-338,231
-330,583
-320,970
-298,212
Total stockholders equity (deficit)
6,550
-33,861
-26,725
-19,423
Total liabilities and stockholders equity (deficit)
62,448
35,331
36,463
41,317
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$46,288K (74.74%↑ Y/Y)Accounts receivable (netof allowance of 98...$6,459K (15.94%↑ Y/Y)Inventory, net$4,205K (10.45%↑ Y/Y)Prepaid expenses$2,792K (25.99%↑ Y/Y)Total current assets$59,744K (56.87%↑ Y/Y)Property and equipment,net$1,837K (7.36%↑ Y/Y)Right-of-use assets$798K (-27.65%↓ Y/Y)Other assets$69K (-83.53%↓ Y/Y)Total assets$62,448K (51.14%↑ Y/Y)Total liabilities andstockholders equity...$62,448K (51.14%↑ Y/Y)Total liabilities$55,898K (-7.97%↓ Y/Y)Total stockholdersequity (deficit)$6,550K (133.72%↑ Y/Y)Accumulated deficit-$338,231K (-13.42%↓ Y/Y)Long-term debt$33,065K (2.45%↑ Y/Y)Total currentliabilities$11,172K (19.82%↑ Y/Y)Warrant liabilities$6,317K (-36.81%↓ Y/Y)Contingent earnoutliability$3,738K (-50.31%↓ Y/Y)Long-term leaseliabilities$1,117K (-11.70%↓ Y/Y)Revenue base redemptionliability$489K (36.59%↑ Y/Y)Additional paid-in capital$344,776K (23.67%↑ Y/Y)Common stock, 0.0001par value,...$5K (66.67%↑ Y/Y)Accrued liabilities$7,107K (0.41%↑ Y/Y)Trade payables$3,763K (97.84%↑ Y/Y)Short-term leaseliabilities$244K (98.37%↑ Y/Y)Other currentliabilities$58K (-73.76%↓ Y/Y)

TriSalus Life Sciences, Inc. (TLSIW)

TriSalus Life Sciences, Inc. (TLSIW)